Clinical trial
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
NCT02368990 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- June 30, 2015
- Completion date
- June 30, 2018
- Enrollment
- 0 (actual)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer